| Literature DB >> 34149338 |
Šime Smolić1, Ivan Čipin2, Petra Međimurec2.
Abstract
This paper combines SHARE Corona Survey and SHARE Wave 7 data for 25 European countries and Israel (N = 40,919) with institutional and epidemic-related country characteristics to investigate healthcare access for Europeans aged 50+ during the outbreak of COVID-19. We use a micro-macro approach to examine whether and to what extent barriers to accessing healthcare measured by reported unmet healthcare needs vary within and between countries. We consider various aspects of barriers and distinguish among: (1) respondents who forewent medical treatment because they were afraid of becoming infected with the Coronavirus; (2) respondents who had pre-scheduled medical appointments postponed by health providers due to the outbreak; and (3) respondents who tried to arrange a medical appointment but were denied one. Limited access to healthcare during the initial outbreak was more common for the occupationally active, women, the more educated and those living in urban areas. A bad economic situation, poor overall health and higher healthcare utilisation were robust predictors of unmet healthcare. People aged 50+ in countries of 'Old' Europe, countries with higher universal health coverage and stricter containment and closure policies were more likely to have medical services postponed. Policymakers should address the healthcare needs of older people with chronic health conditions and a poor socio-economic status who were made more vulnerable by this pandemic. In the aftermath of the health crisis, public health systems might experience a great revival in healthcare demand, a challenge that should be mitigated by careful planning and provision of healthcare services.Entities:
Keywords: Europe; Healthcare access; Older people; Pandemic; SHARE Corona Survey
Year: 2021 PMID: 34149338 PMCID: PMC8195455 DOI: 10.1007/s10433-021-00631-9
Source DB: PubMed Journal: Eur J Ageing ISSN: 1613-9372
Description of the macro-level variables: COVID-19-related and institutional country characteristics, by country
| Sample sizea | COVID-19 morbidityb | COVID-19 mortalityb | Healthcare system | UHC index | CHIc | ‘Old’ versus ‘New’ Europe | |
|---|---|---|---|---|---|---|---|
| Belgium | 3192 | 514.58 | 81.66 | Bismarck | 87 | 62.46 | ‘Old’ Europe |
| Bulgaria | 756 | 35.90 | 2.00 | Bismarck | 63 | 54.04 | ‘New’ Europe |
| Croatia | 1700 | 55.10 | 2.53 | Bismarck | 79 | 68.72 | ‘New’ Europe |
| Cyprus | 556 | 107.66 | 1.94 | Beveridge | 80 | 69.76 | ‘Old’ Europe |
| Czech Republic | 2138 | 86.67 | 3.00 | Bismarck | 82 | 62.69 | ‘New’ Europe |
| Denmark | 1788 | 200.36 | 9.83 | Beveridge | 84 | 55.08 | ‘Old’ Europe |
| Estonia | 3352 | 140.77 | 4.76 | Bismarck | 82 | 49.52 | ‘New’ Europe |
| Finland | 1158 | 123.71 | 5.73 | Beveridge | 91 | 47.74 | ‘Old’ Europe |
| France | 1685 | 226.07 | 42.93 | Bismarck | 91 | 67.24 | ‘Old’ Europe |
| Germany | 2370 | 218.60 | 10.24 | Bismarck | 86 | 58.34 | ‘Old’ Europe |
| Greece | 2280 | 27.18 | 1.63 | Bismarck | 80 | 57.43 | ‘Old’ Europe |
| Hungary | 660 | 39.57 | 5.36 | Bismarck | 72 | 60.43 | ‘New’ Europe |
| Israel | 963 | 199.69 | 3.33 | Bismarck | 81 | 70.52 | ‘Old’ Europe |
| Italy | 2878 | 385.46 | 55.24 | Beveridge | 89 | 74.25 | ‘Old’ Europe |
| Latvia | 849 | 55.47 | 1.25 | Beveridge | 70 | 52.07 | ‘New’ Europe |
| Lithuania | 1093 | 59.77 | 2.51 | Bismarck | 70 | 62.77 | ‘New’ Europe |
| Luxembourg | 667 | 654.18 | 17.92 | Bismarck | 91 | 62.07 | ‘Old’ Europe |
| Malta | 702 | 125.01 | 1.82 | Beveridge | 83 | 72.50 | ‘Old’ Europe |
| Poland | 2628 | 62.07 | 2.79 | Bismarck | 73 | 60.90 | ‘New’ Europe |
| Portugal | 815 | 313.36 | 13.58 | Beveridge | 84 | 63.78 | ‘Old’ Europe |
| Romania | 1259 | 98.55 | 6.45 | Bismarck | 70 | 61.47 | ‘New’ Europe |
| Slovakia | 743 | 27.91 | 0.51 | Bismarck | 78 | 64.00 | ‘New’ Europe |
| Slovenia | 2545 | 70.79 | 5.19 | Bismarck | 90 | 64.80 | ‘New’ Europe |
| Spain | 1509 | 510.11 | 57.79 | Beveridge | 90 | 63.40 | ‘Old’ Europe |
| Sweden | 1075 | 375.27 | 44.96 | Beveridge | 90 | 47.72 | ‘Old’ Europe |
| Switzerland | 1558 | 360.02 | 19.38 | Bismarck | 93 | 54.65 | ‘Old’ Europe |
See text for data sources. aUnweighted values. bRefers to time period until 31 May 2020. cAverage for time period from 12 March 2020 until 31 May 2020
Description of the micro-level SHARE study variables
| Frequency | Per cent | |
|---|---|---|
| 50–64 | 11,460 | 28.01 |
| 65–79 | 21,964 | 53.68 |
| 80 + | 7495 | 18.32 |
| Male | 17,090 | 41.77 |
| Female | 23,829 | 58.23 |
| Low | 13,947 | 34.08 |
| Medium | 17,619 | 43.06 |
| High | 9353 | 22.86 |
| Does not live alone | 32,141 | 78.55 |
| Lives alone | 8778 | 21.45 |
| Rural | 15,519 | 37.93 |
| Urban | 25,400 | 62.07 |
| Retired | 24,884 | 60.81 |
| Working | 9867 | 24.11 |
| Other | 6168 | 15.07 |
| With great difficulty | 3747 | 9.16 |
| With some difficulty | 10,635 | 25.99 |
| Fairly easily | 14,549 | 35.56 |
| Easily | 11,988 | 29.30 |
| Excellent | 2684 | 6.56 |
| Very good | 6489 | 15.86 |
| Good | 18,080 | 44.18 |
| Fair | 10,811 | 26.42 |
| Poor | 2855 | 6.98 |
| About the same | 36,029 | 88.05 |
| Improved | 1177 | 2.88 |
| Worsened | 3713 | 9.07 |
| Yes | 4420 | 10.80 |
| No | 36,499 | 89.20 |
| Yes | 31,819 | 77.76 |
| No | 9100 | 22.24 |
| None | 35,420 | 86.56 |
| 1 | 3817 | 9.33 |
| 2 | 945 | 2.31 |
| 3 + | 737 | 1.80 |
| No ADL limitations | 37,067 | 90.59 |
| 1 + ADL limitations | 3852 | 9.41 |
| No IADL limitations | 34,698 | 84.80 |
| 1 + IADL limitations | 6221 | 15.20 |
| Less than 2 diseases | 19,839 | 48.48 |
| 2 + chronic diseases | 21,080 | 51.52 |
Unweighted values based on combined data from SHARE Wave 7 Release 7.1.1, SHARE Corona Survey Release 0.0.1 beta
Fig. 1Outcomes by country. Notes: Own calculations based on combined data from SHARE Wave 7 Release 7.1.1, SHARE Corona Survey Release 0.0.1 beta (N = 40,919). Error bars represent 95% confidence intervals; the solid vertical line represents the sample average
Determinants of limited access to healthcare for older Europeans due to the outbreak of COVID-19
| Outcome 1: Forwent | Outcome 2: Postponed | Outcome 3: Denied | ||||
|---|---|---|---|---|---|---|
| Pooled | Multilevel | Pooled | Multilevel | Pooled | Multilevel | |
| 50–64 | Ref | Ref | Ref | Ref | Ref | Ref |
| 65–79 | 0.909** | 0.912* | 0.900*** | 0.900*** | 0.881* | 0.879* |
| 80+ | 0.786*** | 0.789*** | 0.643*** | 0.643*** | 0.640*** | 0.638*** |
| Male | Ref | Ref | Ref | Ref | Ref | Ref |
| Female | 1.543*** | 1.541*** | 1.201*** | 1.201*** | 1.102** | 1.102** |
| Low | 0.826*** | 0.825*** | 0.822*** | 0.823*** | 0.877** | 0.879** |
| Medium | Ref | Ref | Ref | Ref | Ref | Ref |
| High | 1.301*** | 1.302*** | 1.156*** | 1.156*** | 1.232*** | 1.239*** |
| Does not live alone | Ref | Ref | Ref | Ref | Ref | Ref |
| Lives alone | 0.983 | 0.984 | 0.967 | 0.967 | 0.999 | 1.003 |
| Rural | 0.944* | 0.942* | 0.954* | 0.954* | 0.885** | 0.885** |
| Urban | Ref | Ref | Ref | Ref | Ref | Ref |
| Retired | 1.112** | 1.109** | 1.053 | 1.053 | 0.961 | 0.959 |
| Working | Ref | Ref | Ref | Ref | Ref | Ref |
| Other | 0.991 | 0.990 | 0.969 | 0.970 | 1.051 | 1.052 |
| With great difficulty | 1.415*** | 1.404*** | 0.984 | 0.977 | 1.406*** | 1.384*** |
| With some difficulty | 1.160*** | 1.152*** | 0.897*** | 0.894*** | 1.087 | 1.082 |
| Fairly easily | 0.998 | 0.993 | 0.930** | 0.930** | 1.010 | 1.013 |
| Easily | Ref | Ref | Ref | Ref | Ref | Ref |
| Excellent | Ref | Ref | Ref | Ref | Ref | Ref |
| Very good | 1.329*** | 1.328*** | 1.094 | 1.094 | 1.396** | 1.397** |
| Good | 1.503*** | 1.498*** | 1.290*** | 1.289*** | 1.630*** | 1.631*** |
| Fair | 1.936*** | 1.927*** | 1.608*** | 1.607*** | 2.153*** | 2.161*** |
| Poor | 2.019*** | 2.006*** | 1.581*** | 1.580*** | 2.580*** | 2.598*** |
| About the same | Ref | Ref | Ref | Ref | Ref | Ref |
| Improved | 1.300*** | 1.302*** | 1.293*** | 1.293*** | 1.131 | 1.131 |
| Worsened | 1.512*** | 1.514*** | 1.238*** | 1.239*** | 1.913*** | 1.919*** |
| Yes | 1.115** | 1.115** | 1.422*** | 1.421*** | 1.479*** | 1.476*** |
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 1.495*** | 1.496*** | 1.876*** | 1.876*** | 1.270*** | 1.266*** |
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| None | Ref | Ref | Ref | Ref | Ref | Ref |
| 1 | 0.978 | 0.979 | 1.173*** | 1.174*** | 1.140* | 1.141* |
| 2 | 1.028 | 1.029 | 1.321*** | 1.320*** | 1.387** | 1.384** |
| 3 + | 1.183 | 1.184 | 1.111 | 1.111 | 1.207 | 1.208 |
| No ADL limitations | Ref | Ref | Ref | Ref | Ref | Ref |
| 1 + ADL limitations | 0.913 | 0.911 | 1.004 | 1.004 | 1.040 | 1.042 |
| No IADL limitations | Ref | Ref | Ref | Ref | Ref | Ref |
| 1 + IADL limitations | 1.003 | 1.004 | 0.923** | 0.923** | 0.829** | 0.828** |
| Less than 2 diseases | Ref | Ref | Ref | Ref | Ref | Ref |
| 2 + chronic diseases | 1.270*** | 1.270*** | 1.258*** | 1.259*** | 1.332*** | 1.333*** |
| Observations | 40,919 | 40,919 | 40,919 | 40,919 | 40,919 | 40,919 |
| Country controls | Yes | No | Yes | No | Yes | No |
| Multilevel ICC (from the null model) | – | 0.063 | – | 0.155 | – | 0.077 |
Odds ratio estimates based on combined data from SHARE Wave 7 Release 7.1.1, SHARE Corona Survey Release 0.0.1 beta (N = 40,919); * p < 0.1, ** p < 0.05, *** p < 0.01
Fig. 2Association between macro-variables and outcomes. Note: own calculations based on SHARE data and various sources of country-level data (see the Data and methods section).
Country-context effects (estimates from multilevel random intercept models)
| Outcome 1: Forwent | Outcome 2: Postponed | Outcome 3: Denied | |
|---|---|---|---|
| Cases per 100,000 | 1.001 | 1.002*** | 1.001** |
| Deaths per 100,000 | 1.001 | 1.011a | 1.009** |
| UHC index | 1.013 | 1.068*** | 1.019 |
| Bismarck | Ref | Ref | Ref |
| Beveridge | 0.952 | 1.318 | 1.153 |
| CHI | 1.005 | 1.043** | 1.007 |
| ‘Old’ Europe | Ref | Ref | Ref |
| ‘New’ Europe | 0.654** | 0.552** | 0.815 |
| Observations | 40,919 | 40,919 | 40,919 |
| Individual-level controls | Yes | Yes | Yes |
Odds ratio estimates based on combined data from SHARE Wave 7 Release 7.1.1, SHARE Corona Survey Release 0.0.1 beta (N = 40,919) and macro-level data from various sources (see text); * p < 0.1, ** p < 0.05, *** p < 0.01; ap = 0.103
Fig. 3Predictive margins at specified values of COVID-19 morbidity and mortality macro-variables. Note: own calculations based on SHARE data and various sources of country-level data (see the Data and methods section)
Fig. 4Predictive margins for ‘Old’ versus ‘New’ European countries
Fig. 5Predictive margins at specified values of UHC index and CHI